(19)
(11) EP 1 678 146 A1

(12)

(43) Date of publication:
12.07.2006 Bulletin 2006/28

(21) Application number: 04769607.5

(22) Date of filing: 11.10.2004
(51) International Patent Classification (IPC): 
C07D 239/42(1985.01)
A61K 31/505(1985.01)
C07D 401/04(1990.01)
A61K 31/506(2000.01)
(86) International application number:
PCT/IB2004/003314
(87) International publication number:
WO 2005/040133 (06.05.2005 Gazette 2005/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 23.10.2003 US 513770 P

(71) Applicant: Pharmacia Corporation
Chesterfield, MO 63017-1732 (US)

(72) Inventors:
  • CLARE, Michael, Pfizer Global Res. and Dev.
    Chesterfield, MO63017-1732 (US)
  • HAGEN, Timothy J., Pfizer Global Res. and Dev.
    Ann Arbor, MI 48105 (US)
  • HOUDEK, Stephen C., Pfizer Global Res. and Dev.
    Chesterfield, MO 63017-1732 (US)
  • LENNON, Patrick J., Pfizer Global Res. and Dev.
    Chesterfield, MO 63017-1732 (US)
  • WEIER, Richard M., Pfizer Global Res. and Dev.
    Chesterfield, MO 63017-1732 (US)
  • XU, Xiangdong, Pfizer Global Res. and Dev.
    Chesterfield, MO 63017-1732 (US)

(74) Representative: Nevant, Marc 
Pfizer European Pharma Patent Department 23-25, avenue du Docteur Lannelongue
75668 Paris Cedex 14
75668 Paris Cedex 14 (FR)

   


(54) PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION